References
- Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP. J Am Acad Child Adolesc Psychiatry 1998; 37(10 Suppl): 63–83S
- Kovacs M. Gender and the course of major depressive disorder through adolescence in clinically referred youngsters. J Am Acad Child Adolesc Psychiatry 2001; 40(9): 1079–85
- Rao U, Ryan ND, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 1995; 34(5): 566–78
- National Institute of Mental Health. Depression in children and adolescents: a fact sheet for physicians. September 2000. Available at: http://www.nimh.nih.gov/publicat/depchildresfact.cfm. Accessed Apr 23, 2002
- National Institute of Mental Health. Suicide fact sheet. Available at: http://www.nimh.nih.gov/publicat/suicidefacts.htm. Accessed Apr 23, 2002
- Lewinsohn PM, Rohde P, Klein DN, et al. Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolesc Psychiatry 1999; 38(1): 56–63
- Kovacs M, Obrosky DS, Gatsonis C, et al. First-episode major depressive and dysthymic disorder in childhood: clinical and sociodemographic factors in recovery. J Am Acad Child Adolesc Psychiatry 1997; 36(6): 777–84
- Kovacs M. Presentation and course of major depressive disorder during childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 1996; 35(6): 705–15
- Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 1996; 35(12): 1575–83
- Varley CK. Sudden death of a child treated with imipramine. Case study. J Child Adolesc Psychopharmacol 2000; 10(4): 321–5
- Green WH. Child and adolescent clinical psychopharmacology. 2nd ed. Baltimore: Williams & Wilkins, 1995: 121–86
- Kye C, Ryan N. Pharmacologic treatment of child and adolescent depression. Child Adolesc Psychiatric Clin North Am 1995; 4(2): 261–81
- Daly JM, Wilens T. The use of tricyclic antidepressants in children and adolescents. Pediatr Clin North Am 1998; 45(5): 1123–35
- Gutgesell H, Atkins D, Barst R, et al. AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry 1999; 38(8): 1047–50
- Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54(11): 1031–7
- Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001; 40(7): 762–72
- Rao U. Longitudinal clinical course of early onset depressive disorders: treatment implications. Child Adolesc Psychopharmacol News 2001; 6(4): 6–11
- Flockhart DA, Oesterheld JR. Cytochrome P450-mediated drug interactions. Child Adolesc Psychiatr Clin North Am 2000; 9(1): 43–76
- Martin A, Kaufman J, Charney D. Pharmacotherapy of early-onset depression: update and new directions. Child Adolesc Psychiatr Clin North Am 2000; 9(1): 135–57